Byondis | ApexOnco - Clinical Trials news and analysis

x

“I am very impressed - it has become my go-to platform”

Chief Business Officer

US public biotech company

Click here for more information

Deals

20 August 2024

Tissue factor tempts Adcendo

Data insights

24 April 2024

Third time lucky for Roche in MAGE-A4?

The Swiss company is still interested in this antigen, after discontinuing two earlier clinical projects.

Two women racing on track, one in front of the other

Trial results

29 November 2023

AbbVie lags J&J in cMet

Conferences

4 September 2023

ESMO 2023 preview – conjugates, bispecifics and more

Deals Trial results

31 August 2023

DualityBio and BioNTech take on Enhertu in HER2 low

Subscribe to Byondis